← Back to headlines





Gilead's HIV Business Surges, Raising Concerns About Franchise Dependency
Gilead Sciences is experiencing a surge in its HIV business, prompting questions about whether the company is becoming overly dependent on a single franchise for its overall success.
23 Aug, 23:15 — 23 Aug, 23:15
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Reports Record Second-Quarter Earnings Driven by Surging AI Demand
43m ago

Universal Studios Japan Announces Nearly $2 Billion Expansion Project
1h ago

Nvidia Earnings Fuel Broad Market Rally Ahead of Jackson Hole Symposium
1h ago
Mixed Corporate Earnings Drive Market Movements as Burlington Slides
1h ago